The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
A lactol that is (-)-noscapine [which is also known as (-)-alpha-narcotine] in which the carbonyl group of the lactone moiety has been reduced to give the corresponding lactol. It is the biosynthetic precursor of (-)-noscapine.
BIRC5 protein results in decreased susceptibility to Noscapine Noscapine promotes the reaction [Cisplatin results in decreased expression of BIRC5 protein] Noscapine results in decreased expression of BIRC5 protein Noscapine results in increased expression of BIRC5 mRNA; Noscapine results in increased expression of BIRC5 protein
[Noscapine co-treated with Cisplatin] results in increased cleavage of CASP3 protein; Noscapine promotes the reaction [Cisplatin results in increased expression of and results in increased cleavage of CASP3 protein]; Noscapine results in increased expression of and results in increased cleavage of CASP3 protein Noscapine results in increased activity of CASP3 protein
Noscapine promotes the reaction [Cisplatin results in increased expression of and results in increased cleavage of CASP9 protein]; Noscapine results in increased expression of and results in increased cleavage of CASP9 protein
Noscapine promotes the reaction [Cisplatin results in increased expression of CDKN1A protein] Noscapine results in increased expression of CDKN1A protein
Noscapine promotes the reaction [Cisplatin results in increased expression of TP53 protein]; Noscapine results in increased expression of and results in increased phosphorylation of TP53 protein Noscapine results in increased expression of TP53 protein